MMSIMerit Medical Systems, Inc.
Price
+4.4%1YEnd-of-day closes, not the intraday tick.
More going right than wrong
Quality strong, no red flags, price roughly fair, growing in the filings, the market undecided.
Merit Medical Systems, Inc. is a leading manufacturer and marketer of proprietary medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy. We strive to be the most customer-focused company in healthcare. Each day we are determined to make a difference by understanding our customers’ needs and innovating and delivering a diverse range of products that improve the lives of people and communities throughout the world.
In the company’s own words · 10-K filed Feb 24, 2026 · SEC EDGAR
Charts
As reported to the SEC, without any scoring.
Merit Medical Systems, Inc. (MMSI) reported revenue of $419M in Q2 2026 (quarter ended Jun 30, 2026), up 9.5% from the same quarter a year earlier. That came with a gross margin of 51% and net income of $39M (9.3% of revenue). For the full year FY2025, revenue was $1.52B (+12% year on year) and net income $128M. Its largest product in Q2 2026 was Therapeutic at $138M, 35% of the disclosed total, well ahead of Foundational Original Equipment Manufacturer at 12%. The next results filing is expected around Oct 29, 2026, the same week as a year ago.
What the company said
The company's own words from its current reports to the SEC, newest first
- Aug 20, 2026On August 14, 2026, Merit Medical Systems, Inc. (“Merit”) reorganized portions of its global operations function. As a result of such reorganization, the position of Chief Operating Officer was eliminated, and Neil W. Peterson’s title was changed to Senior Advisor.Director or officer change · Form 8-K
- Jul 30, 2026Reported revenue of $418.8 million, up 10%.Earnings release · press release
- May 19, 2026At the 2026 Annual Meeting of Shareholders (the “Annual Meeting”) of Merit Medical Systems, Inc. (the “Company”) held on May 13, 2026, the Company’s shareholders approved (i) the Merit Medical Systems, Inc. 2026 Equity Incentive Plan (the “EIP”) and (ii) the Merit Medical Systems, Inc. 2026 Employee Stock Purchase …Director or officer change · Form 8-K
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
Business segments
Jun 2026 · $394.9MThe company’s own SEC segment disclosure.
- Therapeutic$137.9M35%
- Foundational Original Equipment Manufacturer$48.3M12%
- Foundational Vascular Intervention$41.7M11%
- Therapeutic Vascular Intervention$34.4M9%
- Therapeutic Cardiac Therapies$28.5M7%
- Foundational Procedural Solutions$27.9M7%
- Other (5)$76.2M19%
Why these answers
Each answer with the checks it was read from. Open one for the numbers.
Conflicts between checks are named, never averaged, and thin data says so.
Medical Instruments & Supplies
Ranks #5 of 21 by RyuScore